S. Jozan

1.0k total citations
45 papers, 895 citations indexed

About

S. Jozan is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, S. Jozan has authored 45 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Genetics and 14 papers in Oncology. Recurrent topics in S. Jozan's work include Estrogen and related hormone effects (15 papers), Retinoids in leukemia and cellular processes (5 papers) and Cancer-related Molecular Pathways (5 papers). S. Jozan is often cited by papers focused on Estrogen and related hormone effects (15 papers), Retinoids in leukemia and cellular processes (5 papers) and Cancer-related Molecular Pathways (5 papers). S. Jozan collaborates with scholars based in France, United States and Switzerland. S. Jozan's co-authors include Annie Valette, F. Bayard, Monique Courtade-Saïdi, Laetitia Lacoste-Collin, Simone Vidal, R. Bugat, Nadia Barboule, Véronique Baldin, J.C. Faye and C. Caratero and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

S. Jozan

45 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Jozan France 19 449 250 237 116 100 45 895
Tomoko Nii Japan 11 563 1.3× 180 0.7× 168 0.7× 59 0.5× 91 0.9× 19 1.1k
Wesley O. McBride United States 10 617 1.4× 216 0.9× 199 0.8× 61 0.5× 166 1.7× 13 1.1k
Pasquale Piccolo Italy 17 372 0.8× 141 0.6× 259 1.1× 103 0.9× 68 0.7× 39 1.1k
J.R. Puddefoot United Kingdom 20 453 1.0× 130 0.5× 271 1.1× 35 0.3× 82 0.8× 58 1.2k
Birgit Gaßner Germany 22 759 1.7× 148 0.6× 144 0.6× 128 1.1× 181 1.8× 34 1.4k
Virginia Novaro Argentina 19 375 0.8× 246 1.0× 174 0.7× 118 1.0× 135 1.4× 42 907
B.N. Díaz-Chico Spain 18 431 1.0× 189 0.8× 318 1.3× 49 0.4× 160 1.6× 63 1.0k
George Lam United States 15 639 1.4× 159 0.6× 82 0.3× 144 1.2× 106 1.1× 22 1.0k
J. Antonie Maassen Netherlands 21 974 2.2× 133 0.5× 175 0.7× 190 1.6× 70 0.7× 42 1.3k
H Nawata Japan 12 540 1.2× 77 0.3× 204 0.9× 137 1.2× 112 1.1× 31 1.0k

Countries citing papers authored by S. Jozan

Since Specialization
Citations

This map shows the geographic impact of S. Jozan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jozan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jozan more than expected).

Fields of papers citing papers by S. Jozan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jozan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jozan. The network helps show where S. Jozan may publish in the future.

Co-authorship network of co-authors of S. Jozan

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jozan. A scholar is included among the top collaborators of S. Jozan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jozan. S. Jozan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacoste-Collin, Laetitia, et al.. (2014). Influence of a Continuous Very Low Dose of Gamma-Rays on Cell Proliferation, Apoptosis and Oxidative Stress. Dose-Response. 1(-1). 1–17. 48 indexed citations
2.
Vaysse, Laurence, Benoit Canolle, S. Jozan, et al.. (2012). Adult human progenitor cells from the temporal lobe: Another source of neuronal cells. Brain Injury. 26(13-14). 1636–1645. 8 indexed citations
3.
Lacoste-Collin, Laetitia, et al.. (2009). Cut‐off values and significance of Oil Red O‐positive cells in bronchoalveolar lavage fluid. Cytopathology. 21(4). 245–250. 32 indexed citations
4.
Lobjois, Valérie, Céline Frongia, S. Jozan, Isabelle Truchet, & Annie Valette. (2009). Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids. European Journal of Cancer. 45(13). 2402–2411. 30 indexed citations
5.
Truchet, Isabelle, S. Jozan, Silvère Baron, et al.. (2008). Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment. International Journal of Oncology. 32(5). 1033–9. 13 indexed citations
6.
Lacoste-Collin, Laetitia, S. Jozan, Bernard Pipy, et al.. (2007). Effect of Continuous Irradiation with a Very Low Dose of Gamma Rays on Life Span and the Immune System in SJL Mice Prone to B-Cell Lymphoma. Radiation Research. 168(6). 725–732. 40 indexed citations
7.
Jozan, S., Jacqueline Aziza, Sophie Châtelin, et al.. (2007). Human fetal chromaffin cells: A potential tool for cell pain therapy. Experimental Neurology. 205(2). 525–535. 18 indexed citations
8.
Jozan, S., et al.. (2001). Influence of continuous, very low-dose gamma-irradiation on the mouse immune system. International Journal of Radiation Biology. 77(5). 587–592. 18 indexed citations
9.
Truchet, Isabelle, S. Jozan, Marina Guerrin, et al.. (2000). Interconnections between E2-Dependent Regulation of Cell Cycle Progression and Apoptosis in MCF-7 Tumors Growing on Nude Mice. Experimental Cell Research. 254(2). 241–248. 18 indexed citations
11.
Barboule, Nadia, Véronique Baldin, S. Jozan, Simone Vidal, & Annie Valette. (1998). Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PNCA. International Journal of Cancer. 76(6). 891–896. 35 indexed citations
12.
13.
Lafon, Corinne, Isabelle Lochon, A Nehmé, et al.. (1997). Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. British Journal of Cancer. 75(3). 333–340. 29 indexed citations
14.
Mathieu, Chantal, et al.. (1995). Density-Dependent Induction of Apoptosis by Transforming Growth Factor-β1 in a Human Ovarian Carcinoma Cell Line. Experimental Cell Research. 216(1). 13–20. 30 indexed citations
15.
Nehmé, A, Nicolas Albin, Sylvie M. Guichard, et al.. (1995). Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian‐cancer cell lines. International Journal of Cancer. 61(5). 643–648. 12 indexed citations
16.
Guichard, Sylvie M., et al.. (1994). Response of four human ovarian carcinoma cell lines to ALL‐TRANS retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression. International Journal of Cancer. 56(5). 743–748. 39 indexed citations
17.
Roché, H., S. Jozan, Claude P. Muller, et al.. (1993). Characterization and chemosensitivity of a human epithelioid sarcoma cell line (SARCCR 2). International Journal of Cancer. 54(4). 663–668. 8 indexed citations
18.
Jozan, S., Marina Guerrin, Marianne Dutaur, et al.. (1992). Transforming growth factor β1 (TGF‐β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors. International Journal of Cancer. 52(5). 766–770. 20 indexed citations
19.
Jozan, S., et al.. (1991). 65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness. Breast Cancer Research and Treatment. 19(2). 103–109. 12 indexed citations
20.
Darbon, Jean-Marie, Annie Valette, S. Jozan, Marc Issandou, & Françis Bayard. (1990). Dissociation between protein kinase C content and biological responsiveness to phorbol esters in tumor promoter-sensitive (MCF-7) and resistant (RPh-4) cells. Biochemical Pharmacology. 40(8). 1785–1792. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026